Lixisenatide for type 2 diabetes

Med Lett Drugs Ther. 2017 Jan 30;59(1513):19-21.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic / methods
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism
  • Glucagon-Like Peptide-1 Receptor / agonists*
  • Glucagon-Like Peptide-1 Receptor / metabolism
  • Humans
  • Hypoglycemic Agents / metabolism
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Peptides / metabolism
  • Peptides / pharmacology
  • Peptides / therapeutic use*

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Peptides
  • lixisenatide